Diabetes patients can be a target for chronic kidney disease but can also take aim back: This is the message from AstraZeneca’s new Farxiga TV ad, which is pushing the drug’s new CKD label. There is ...
AstraZeneca’s latest DTC spot “We Are Targets” for its chronic kidney disease (CKD) med Farxiga is aimed squarely at the nine in 10 adults who have CKD but are unaware of it. The new spot is a ...
The US Food and Drug Administration (FDA) on Monday published an untitled letter it sent to AstraZeneca on 23 September concerning a TV commercial for its drug Farxiga (dapagliflozin). Regulators ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results